Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jul 9;93(14):6913-7.
doi: 10.1073/pnas.93.14.6913.

The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B

Affiliations

The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B

M J van Raaij et al. Proc Natl Acad Sci U S A. .

Abstract

In the structure of bovine mitochondrial F1-ATPase that was previously determined with crystals grown in the presence of adenylyl-imidodiphosphate (AMP-PNP) and ADP, the three catalytic beta-subunits have different conformations and nucleotide occupancies. Adenylyl-imidodiphosphate is bound to one beta-subunit (betaTP), ADP is bound to the second (betaDP), and no nucleotide is bound to the third (betaE). Here we show that the uncompetitive inhibitor aurovertin B binds to bovine F1 at two equivalent sites in betaTP and betaE, in a cleft between the nucleotide binding and C-terminal domains. In betaDP, the aurovertin B pocket is incomplete and is inaccessible to the inhibitor. The aurovertin B bound to betaTP interacts with alpha-Glu399 in the adjacent alphaTP subunit, whereas the aurovertin B bound to betaE is too distant from alphaE to make an equivalent interaction. Both sites encompass betaArg-412, which was shown by mutational studies to be involved in binding aurovertin. Except for minor changes around the aurovertin pockets, the structure of bovine F1-ATPase is the same as determined previously. Aurovertin B appears to act by preventing closure of the catalytic interfaces, which is essential for a catalytic mechanism involving cyclic interconversion of catalytic sites.

PubMed Disclaimer

References

    1. Biochem Biophys Res Commun. 1965 Oct 26;21(2):170-5 - PubMed
    1. Biochemistry. 1964 Dec;3:1961-8 - PubMed
    1. Biochem J. 1968 Jul;108(3):445-56 - PubMed
    1. J Biol Chem. 1973 Apr 25;248(8):2746-54 - PubMed
    1. Biochim Biophys Acta. 1973 Jun 28;305(3):503-18 - PubMed

Publication types

LinkOut - more resources